New asthma clinical trial: PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

Published on: October 17, 2019 at 07:00PM
Condition:   Asthma
Interventions:   Drug: MCT;   Drug: Clazakizumab;   Drug: Broncho-Vaxom;   Drug: Imatinib Mesylate;   Drug: Cavosonstat;   Drug: Itacitinib;   Other: Placebo
Sponsors:   University of North Carolina, Chapel Hill;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting